Name: Xiaoxi ZHANG
Associate Research Professor
School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicinee
Email: zhangxiaoxi@sjtu.edu.cn
Tel: 021-63846590*776974
Research Area: Health system and policy, One Health governance
Dr. Xiaoxi Zhang is an Associate Research Professor at the School of Global Health, Shanghai Jiao Tong University School of Medicine. Currently, she serves as the member of Global Health Governance Expert Working Group for the National Disease Control and Prevention Administration of China, the consultant for WHO Academy and the World Bank, and the secretary general for One Health Action Commission. She has extensive publications in impactful academic journals including The Lancet Regional Health, The Lancet, Nature, Infectious Diseases of Poverty and One Health. Her work has been selected in the top 100 of China’s medical science papers of 2022 by the Chinese Medical Association. Before commencing Shanghai Jiao Tong University, she interned for the World Health Organization headquarter and Egypt country office. She has strong research interests in health governance and health policy research, and hopes her research could bring real-world impact to the system building of One Health.
Education:
2008.09 – 2013.06, Bachelor of Medicine, Southeast University, Nanjing, China
2013.08 – 2015.05, Master of Science, Duke University, Durham, USA
2018.09 – 2021.07, PhD in Economics, Shanghai Academy of Social Sciences, Shanghai, China
Working experience:
2014.05 – 2014.07, Intern, World Health Organization (WHO) Representative Office, Cairo, Egypt
2015.05 – 2015.08, Intern, World Health Organization (WHO) Headquarter, Geneva, Switzerland
2015.09 – 2021.07, Research Analyst, Shanghai Health Development Research Center, Shanghai, China
2020.02 – 2021.02, Secondment, Shanghai Municipal Health Commission, Shanghai, China
2021.08 – 2024.01, Assistant Research Professor, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2025.01 – 2025.06, Consultant, World Health Organization Academy, Lyon, France
2024.02 – Present, Associate Research Professor, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Selected publications (first author and corresponding author only):
1.Zhang XX, Guo XK, Zhou XN. One Health: a key element in the WHO Pandemic Agreement. The Lancet 2025, 405(10496): 2197–2198.
2.Xiaoxi Zhang, Armand Zimmerman, Yanyan Zhang, et al. Rapid growth of private hospitals in China: emerging challenges and opportunities to health sector management. The Lancet Regional Health - Western Pacific 2024, 44: 100991.
3.Liu JS#, Li XC#, Zhang QY#, Han LF, Xia S, etc., Zhang XX. China's application of the One Health approach in addressing public health threats at the human-animal-environment interface: Advances and challenges. One Health 2023, 17: 100607.
4.Zhang XX, Liu JS, Han LF, Simm G, Guo XK, Zhou XN. One Health: new evaluation framework launched. Nature 2022, 604(7907): 625.
5.Zhang XX#, Liu JS#, Han LF, Xia S, Li S-Z, Li OY, Kassegne KK, Li M, Yin K, Hu QQ, Xiu LS, Zhu YY, Huang LY, Wang XC, Zhang Y, Zhao HQ, Yin JX, Jiang TG, Li Q, Fei SW, Gu SY, Chen FM, Zhou N, Cheng ZL, Xie Y, Li HM, Chen J, Guo ZY, Feng JX, Ai L, Xue JB, Ye Q, Grant L, Song JX, Simm G, Utzinger J, Guo XK, Zhou XN. Towards a global One Health index: a potential assessment tool for One Health performance. Infect Dis Poverty 2022, 11(1): 57.
6.Sun ZS#, Zhou H#, Chen FM#, Lu SN, Liang H, Wan EY, Tao ZC, Zhao HQ, Zhou XN, Yang F*, Wang DQ*, Zhang XX*. Understanding the China-Tanzania Malaria Control Project: Lessons learned from a multi-stakeholder qualitative study. Frontiers in Public Health 2023, 11: 1229675.
7.Li, X. C., Qian, H. R., Zhang, Y. Y., Zhang, Q. Y., Liu, J. S., Lai, H. Y., Zheng, W. G., Sun, J., Fu, B., Zhou, X. N., & Zhang, X. X. Optimal decision-making in relieving global high temperature-related disease burden by data-driven simulation. Infectious Disease Modelling 2024, 9(2): 618–633.
8.Zhang XX#, Li XC#, Zhang QY#, Liu JS, Han LF, Lederman Z, etc. Tackling global health security by building an academic community for One Health action. Infect Dis Poverty 2023, 12(1): 70.
9.Zhang, X., Zimmerman, A., Lai, H., Zhang, Y., Tang, Z., Tang, S., & Ogbuoji, O. Differential effect of China's Zero Markup Drug Policy on provider-induced demand in secondary and tertiary hospitals. Frontiers in public health 2024, 12: 1229722.
10.Zhang, X. X., Lederman, Z., Han, L. F., Schurer, J. M., Xiao, L. H., Zhang, Z. B., Chen, Q. L., Pfeiffer, D., Ward, M. P., Sripa, B., Gabriël, S., Dhama, K., Acharya, K. P., Robertson, L. J., Deem, S. L., Aenishaenslin, C., Dantas-Torres, F., Otranto, D., Grace, D., Wang, Y., … Zhou, X. N. Towards an actionable One Health approach. Infectious diseases of poverty 2024, 13(1): 28.
11.Xiaoxi Zhang, Hongyu Lai, Lidan Zhang, Jiangjiang He, Bo Fu, Chunlin Jin. The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China. BMC Health Services Research 2020, 20:1058-1069.
12.Zhang X-X#, Jin Y-Z#, Lu Y-H, Huang L-L, Wu C-X, Lv S, Chen Z, Xiang H*, Zhou X-N*. Infectious disease control: from health security strengthening to health systems improvement at global level. Global Health Research and Policy 2023, 8(1): 38.
13.Zhang, Q., Liu, J., Han, L., Li, X., Zhang, C., Guo, Z., Chao, A., Wang, C., Wan, E., Chen, F., Zhao, H., Feng, J., Xue, J., Huang, L., Chen, J., Sun, Z., Cheng, Z., Yin, J., He, Z., Huang, L., … Zhang, X.,Zhou, X. N. How far has the globe gone in achieving One Health? Current evidence and policy implications based on global One Health index. Science in One Health 2024, 3: 100064.
14.Li, X. C., Zhang, Y. Y., Zhang, Q. Y., Liu, J. S., Ran, J. J., Han, L. F., & Zhang, X. X. Global burden of viral infectious diseases of poverty based on Global Burden of Diseases Study 2021. Infectious diseases of poverty 2024, 13(1): 71.
15.Li, X., Zhang, Y., Zhang, Q., Liu, J., Zhu, Z., Feng, X., Han, L., & Zhang, X. Strategy and mechanism of One Health governance: case study of China. Science in One Health 2024, 4: 100098.
16.[in Chinese] Xiaoxi Zhang, Yuying Sun, Baosong Zhou, etc. Study on the efficiency of health development in the Yangtze River Delta Region of China. Health Economics Research 2020, 37(01):18-21.
17.[in Chinese] Xiaoxi Zhang, Jun Ren, Chunlin Jin. Analysis of the achievement of the health development planning in Beijing and Shanghai from 2010 to 2017. Chinese Health Resources 2019, 22(02): 99-105.
18.[in Chinese] Xiaoxi Zhang, Fen Li, Chunlin Jin. Analysis on the influencing factors and development trend of the health expenditure in Shanghai from 2001 to 2017. Health Economics Research 2019, 36(09): 29-32.
19.[in Chinese] Xiaoxi Zhang, Xianmei Wang, Jun Ren, et al. Multi-dimensional evaluation and analysis of health system performance in Beijing and Shanghai. Chinese Health Economics 2019, 38(06): 12-16.
Selected research projects:
1.Principal: Research on the Decision-making Mechanism and Implementation Path of Control and Prevention for Zoonosis Based on the Concept of One Health, Youth Project of National Natural Science Foundation of China (2023-2025)
2.Principal: Topical Diseases One Health Decision-making System Construction and Path Optimization, Open Research Project of Key Laboratory of Parasite Pathogens and Vector Biology of the National Health Commission of China (2022-2025)
3.Principal: Research on One Health-Based Decision-Making Pathways for the Prevention and Control of Zoonoses, Health Industry Clinical Research Special Project of Shanghai Municipal Health Commission (2024-2027)
4.Sub-project Principal: Research on the Dynamics and Driving Factors of Antimicrobial Resistance in China and the UK Based on the One Health Approach, National Key R&D Program Intergovernmental International Science and Technology Innovation Cooperation Special Project (2024-2027)
5.Principal: Shanghai Health Technology Innovation Cluster Development Path and Efficiency Evaluation, Technology Innovation Action Plan Soft Science Key Project of Shanghai Science and Technology Commission (2020-2021)
6.Principal: Cooperative Mechanism and Performance Evaluation of the Medical Consortium in the Yangtze River Delta Region from the Integrated Development Perspective, Special Project of Social Science Planning Offices of Shanghai, Jiangsu, Zhejiang and Anhui (2019-2020)
7.Sub-project Principal: One Health Action Commission, funded by the Bill and Melinda Gates Foundation (USA) (2022-2023)